Table TDI-5. Primary drug and rates of injection of primary drug of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (iv) All clients by country and rates of injection of primary drug (%)

Country		Year	Opioids % injecting	Cocaine % injecting	Amphetamines % injecting	Total % injecting
Belgium	(1)	2005	20.6	10.4	18.6	12.6
Bulgaria		2008	82.4	0.0	0.0	79.5
Czech Republic		2008	86.1	5.0	80.1	69.3
Denmark	(2)	2008	20.2	7.8	3.9	9.1
Germany	(3)	2008	41.0	23.2	2.2	16.6
Estonia		2008	91.4		63.6	89.4
Ireland		2008	37.3	2.2	0.0	24.1
Greece		2008	39.2	5.5	0.0	33.7
Spain	(4)	2007	18.8	2.2	0.5	8.1
France		2008	23.7	13.0	9.4	10.3
Italy		2008	60.9	4.4	0.0	35.4
Cyprus		2008	65.1	2.4	0.0	36.3
Latvia	(5)	2008	92.6		64.5	66.9
Lithuania	(6)	2008	99.3	25.0	61.4	93.2
Luxembourg		2008	64.6	45.5	0.0	59.0
Hungary		2008	73.9	6.2	24.1	11.5
Malta	(7)	2006	75.7	30.9		60.9
Netherlands		2008	5.1	0.4	2.0	1.3
Austria		2008	48.7	11.1	0.0	34.1
Poland	(8)	2007
Portugal	(9)	2008
Romania		2008	94.9	0.0	0.0	70.6
Slovenia		2008	54.7	44.4		52.7
Slovakia		2008	86.3	0.0	36.3	48.9
Finland		2008	82.4	0.0	82.0	62.7
Sweden		2008	52.3	5.6	57.0	30.9
United Kingdom		2008	36.2	3.6	24.4	23.8
Croatia		2008	74.4	0.7	0.0	58.7
Turkey		2008	45.9	2.8	0.0	24.0
Norway
Total			42.7	7.4	29.0	23.0

Notes:

 Drug specific percentages are of clients whose primary drug and usual route of administration is known. Total considers all the injection cases regardless of the primary drug being known or not. 

 Injecting as a route of administration is not reported for ecstasy, cannabis and other drugs. 

 When proportion of clients by main drug is 0, ‘% of injectors’ is blank. If no data is available, the symbol ":" is used. 

 (1) Last data available refer to 2005. Data refer only to outpatient and low-threshold agencies. Data do not cover Brussels Capital Region. 

 (2) Most of injection cases have been reported under unknown primary drug. 

 (3) Data on amphetamines refer to stimulants in general. Data on route of administration refer to primary and non primary drugs. 

 (4) Last data available refer to 2007. 

 (5) Data refer only to inpatient centres for which information on all clients have been reported. 

 (6) Data on amphetamines include amphetamines and ecstasy. 

 (7) Last data available refer to 2006. 

 (8) No data available. 

 (9) Data only available for new clients. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2009 — TDI tables V. 1.0-2008 (question 16.1.1) See Table TDI-0 for details on sources. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)